Phage Biopesticides: How They Work, Which Products Exist and What Farmers Should Know

Bacteriophages are beginning to move from experimental plant pathology into commercial crop protection. Several phage-based bactericides are now registered in the United States, China has registered its first crop bacteriophage pesticide, European growers have received temporary access to phage products against fire blight, and additional programmes are progressing through regulatory development in North America, Europe and Latin America.

The market remains much smaller than the markets for conventional pesticides or microbial biocontrol products. It is also easy to misunderstand. A company announcing a distribution agreement does not necessarily mean that its product is legally authorized for use in that country. A successful field trial does not equal registration, and an emergency authorization valid for a few months in one European country is not the same as an EU-wide approval.

This guide separates commercially registered products from temporary authorizations and development programmes, explains which pathogens they target, how farmers actually use them, where they can currently be obtained and what limitations need to be considered before incorporating phages into an integrated crop-protection programme.

Figure. Bacteriophage-based crop protection: target crops, bacterial pathogens, and associated products.

Overview of ten economically important crops targeted by bacteriophage-based biocontrol strategies: tomato, pepper, apple, pear, citrus, grapevine, peach, almond, banana, and ginger. The infographic highlights representative products and development programmes, including GoldenEco, DCM PEA-02, Erwiphage Plus, LeJu (YHC5), XylPhi-PD, AgriPhage, EcoStonia, and Phagelux's ginger programme. These approaches target specific bacterial plant pathogens and represent different stages of regulatory approval and commercial development. Plant photographs are illustrative and do not constitute experimental evidence of treatment efficacy. Product packaging illustrations are not verified photographs of commercial formulations.

What is a phage biopesticide?

A bacteriophage is a virus that infects bacteria rather than plant, animal or human cells. A lytic phage recognizes susceptible bacteria, attaches to a compatible receptor, injects its genome, replicates inside the bacterial cell and eventually lyses it, releasing new phage particles capable of attacking neighbouring susceptible bacteria.

Agricultural products generally combine several lytic phages into a cocktail. This can broaden activity against genetically diverse strains of the same pathogen and reduce the probability that a single bacterial mutation makes the entire product ineffective.

This specificity is one of the main attractions of the technology. A phage targeting Erwinia amylovora, for example, is not intended to indiscriminately remove the rest of the microbial community associated with an apple tree. Conventional copper bactericides and antibiotics can exert much broader antimicrobial pressure.

Specificity is also one of the technology's main limitations. A phage effective against one bacterial strain may not infect another strain of the same species. Commercial developers therefore need large collections of pathogen isolates and phages and must continuously verify whether the cocktail covers bacterial populations circulating in the regions where the product will be used.

The global crop-protection landscape in 2026

The United States currently has the most mature regulatory and commercial market for crop-protection bacteriophages. OmniLytics, now part of Phagelux AgriHealth, has built the AgriPhage line around several EPA-registered products covering bacterial diseases of tomatoes, peppers, apples, pears, citrus, stone fruit and nuts. A&P Inphatec, an Otsuka group company, separately commercializes XylPhi-PD for Pierce's disease of grapevines.

EcoPhage became another significant US entrant in September 2026 when the EPA approved GoldenEco for bacterial spot and speck of tomatoes and peppers. Its four subsequent products remain at earlier regulatory stages.

China represents the other major regulatory development. In 2025, Phagelux Nanjing Biotechnology obtained pesticide registrations for Xanthomonas axonopodis phage YHC5, including a formulated product against citrus canker. Phagelux markets its Chinese citrus programme as LeJu and maintains additional pipelines against ginger wilt and kiwifruit canker.

Europe remains more complicated. No broad permanent EU market comparable with the United States has yet emerged, but DCM PEA-02 received temporary emergency authorizations in several European countries during 2026 while its broader European regulatory process continues. Hungary also has a history of temporary authorization of Enviroinvest's Erwiphage products against fire blight.

Latin America is increasingly important commercially, although distribution agreements should not be confused with national pesticide registrations. EcoPhage has agreements involving GoldenEco in Brazil and GoldenEco and EcoFire in Mexico, while its EcoStonia programme is being evaluated with Dole against Moko disease of bananas in Central and Latin America.

For Africa and Oceania, research on agricultural bacteriophages exists, but in the sources reviewed for this guide I could not verify a comparable named, nationally registered crop-protection phage pesticide currently marketed there. That is different from saying that phages are not being researched or used experimentally in those regions.

Global directory of named phage crop-protection products and programmes

The table below includes the publicly identifiable named products and advanced development programmes I could verify as of October 2026. It deliberately distinguishes registration from submission, emergency authorization and experimental development.

Product	Company / developer	Main target pathogen	Crops / use	Region	Status as of Oct. 2026	Typical application
AgriPhage Spot & Speck	OmniLytics / Phagelux AgriHealth	Xanthomonas spp.; Pseudomonas syringae pv. tomato	Tomato, pepper	United States	EPA registered (Reg. No. 67986-1); commercial product	Foliar and greenhouse spray
AgriPhage Tomato Canker	OmniLytics / Phagelux AgriHealth	Clavibacter michiganensis	Tomato	United States	EPA registered (Reg. No. 67986-6); commercial product	Foliar treatment
AgriPhage CMM	OmniLytics / Phagelux AgriHealth	Clavibacter michiganensis	Greenhouse tomato	Canada	Registered with PMRA (Reg. No. 30301)	Greenhouse crop treatment
AgriPhage Fire Blight	OmniLytics / Phagelux AgriHealth	Erwinia amylovora	Apple, pear	United States	EPA registered (Reg. No. 67986-8); commercial product	Orchard / foliar application
AgriPhage Citrus Canker	OmniLytics / Phagelux AgriHealth	Xanthomonas citri	Orange, grapefruit and other citrus	United States	EPA registered (Reg. No. 67986-9); commercial product	Foliar spray
AgriPhage Nut & Stone Fruit	OmniLytics / Phagelux AgriHealth	Xanthomonas arboricola pathovars; Pseudomonas syringae pv. syringae	Peach, cherry, almond, walnut, hazelnut and related crops	United States	EPA registered (Reg. No. 67986-10); commercial product	Foliar / orchard spray
XylPhi-PD	A&P Inphatec / Otsuka	Xylella fastidiosa subsp. fastidiosa	Grapevine / Pierce's disease	United States	EPA registered (Reg. No. 93909-1); commercial use, particularly in California	Direct injection into grapevine xylem
GoldenEco	EcoPhage	Xanthomonas spp.; Pseudomonas syringae pv. tomato	Tomato, pepper	United States	US EPA approval announced in September 2026; commercial rollout remains subject to applicable state registrations	Foliar spray
GoldenEco	EcoPhage + Maian	Xanthomonas spp.; Pseudomonas syringae pv. tomato	Tomato, pepper	Brazil	Distribution agreement announced; this alone does not establish Brazilian regulatory authorization	Intended foliar use
GoldenEco	EcoPhage + Agricultura Nacional / Dragon	Xanthomonas spp.; Pseudomonas syringae pv. tomato	Tomato, pepper	Mexico	Distribution agreement announced in October 2026; not evidence by itself of Mexican regulatory registration	Intended foliar use
EcoFire	EcoPhage	Erwinia amylovora	Apple, pear	United States	EPA application submitted; approval not established in sources reviewed as of October 2026	Foliar / orchard treatment
EcoFire	EcoPhage + Agricultura Nacional / Dragon	Erwinia amylovora	Apple, pear	Mexico	Distribution agreement announced; Mexican regulatory availability requires separate confirmation	Intended foliar / orchard treatment
EcoBrass	EcoPhage	Xanthomonas campestris pv. campestris	Cabbage, broccoli, kale and other Brassicaceae	United States	EPA application submitted in January 2026; not yet a confirmed commercial registration	Foliar crop protection
EcoStraw	EcoPhage	Xanthomonas fragariae	Strawberry	United States	EPA application submitted in April 2026; not yet a confirmed commercial registration	Preventive foliar treatment
EcoSpud	EcoPhage	Pectobacterium spp.; Dickeya spp.	Potato	United States	EPA application submitted in July 2026; not yet a confirmed commercial registration	Preventive potato disease management
EcoStonia	EcoPhage	Moko disease-associated Ralstonia solanacearum species complex	Banana	Latin America	Development and evaluation programme, including collaboration with Dole; not a broadly registered commercial product	Application programme under development, including fertigation approaches
DCM PEA-02	DCM	Erwinia amylovora	Apple, pear	European Union / selected European countries	Full EU authorization process ongoing; temporary or emergency authorizations reported in several European countries during 2026	Professional orchard treatment
Erwiphage / Erwiphage Forte / Erwiphage Plus	Enviroinvest	Erwinia amylovora	Apple, pear and other pome fruits	Hungary / Europe	Historically used under national temporary authorizations; current authorization should be checked for the relevant season and country	Foliar treatment during periods of high fire-blight risk
PhageFire	Enviroinvest / ZHAW / Kimitec / Peras de Rincón de Soto consortium	Erwinia amylovora	Apple, pear, quince	European Union	Development / pre-commercial programme; not a generally authorized EU plant-protection product	Orchard / foliar strategy under development
LeJu / YHC5 phage formulation	Phagelux Nanjing Biotechnology / Phagelux AgriHealth	Xanthomonas citri / citrus canker-associated pathogen	Citrus	China	Registered phage formulation in 2025 (Reg. No. PD20252172)	Foliar crop treatment
YHC5 technical concentrate	Phagelux Nanjing Biotechnology	Bacteriophage YHC5 targeting citrus canker-associated Xanthomonas	Technical manufacturing material	China	Registered technical material (Reg. No. PD20252165); not intended for direct crop application	Manufacture of formulated phage products
LeJiang	Phagelux AgriHealth	Ralstonia solanacearum	Ginger	China / Asia	Public crop-science development pipeline; commercial regulatory status not confirmed in sources reviewed	Crop treatment under development
LeQi	Phagelux AgriHealth	Pseudomonas syringae	Kiwifruit	China / Asia	Public development pipeline; regulatory registration not confirmed in sources reviewed	Crop treatment under development
Biolyse-PB	APS Biocontrol	Pectobacterium spp. and related soft-rot bacteria	Stored potato tubers	United Kingdom / Europe	Commercial post-harvest biocontrol product; regulatory category differs from an EU field plant-protection product	Post-harvest potato treatment

Important: inclusion in this table does not mean that a product is legally available everywhere in the listed region. Only products explicitly described as registered or authorized should be treated as such. Distribution agreements, regulatory submissions, development programmes and temporary authorizations are shown separately. Growers should always verify the current national or state registration, approved crops, label, application rate and professional-use requirements before purchasing or applying a phage-based product.

This distinction matters. Only the entries explicitly listed as registered or authorized should be treated as legally usable pesticides in the corresponding jurisdictions without further verification. Regulatory permissions can also be crop-specific, state-specific, professional-use-only or limited to a defined season.

United States: the most established commercial market

The AgriPhage family remains the clearest example of routine agricultural phage use. OmniLytics began commercial crop applications in North America more than two decades ago and now operates within Phagelux AgriHealth. Five US EPA registration numbers cover the company's main crop bactericides.

For tomato and pepper growers, AgriPhage Spot & Speck targets bacterial spot and bacterial speck. Tomato Canker addresses Clavibacter michiganensis. Orchard products extend the approach to Erwinia amylovora in apples and pears, Xanthomonas citri in citrus and several Xanthomonas and Pseudomonas diseases of stone fruit and nuts.

The company recommends integrating these products into existing IPM programmes rather than treating phages as a universal replacement for every other crop-protection measure. Rates and intervals vary with the product, crop, disease pressure and label.

One practical issue is tank compatibility. Because phages are biological particles, disinfectants and some bactericidal products can destroy them before they reach the crop. OmniLytics specifically warns about chlorinated water, high concentrations of certain clay products and some copper formulations, although many fungicides, insecticides, fertilizers and surfactants can be compatible when used under tested conditions.

Growers should therefore follow the current compatibility list and label rather than assuming that a phage product can be mixed with any pesticide already present in the spray programme.

XylPhi-PD: a very different application method

XylPhi-PD shows that agricultural phages do not necessarily have to be sprayed onto a leaf.

The product was developed through work involving Otsuka Pharmaceutical, A&P Inphatec and Texas A&M researchers against Xylella fastidiosa, the vascular bacterium responsible for Pierce's disease of grapevines.

Instead of foliar spraying, XylPhi-PD is injected directly into the vine. This brings the phage treatment into the xylem, where Xylella lives, and reduces some of the environmental exposure associated with spraying viruses onto plant surfaces.

The product has federal EPA registration and remains commercially available in California through agricultural distribution channels including Wilbur-Ellis. It is also OMRI-listed for organic production.

This delivery method has advantages but also practical costs. Every vine needs to be treated individually, making labour and equipment very different from conventional broadcast spraying. It is therefore particularly suited to high-value perennial crops such as vineyards rather than low-value broadacre crops.

EcoPhage: one approval and a rapidly growing pipeline

EcoPhage has become one of the most active new developers in the sector.

Its first approved US product, GoldenEco, received EPA approval in September 2026. The product contains a selected phage cocktail targeting bacterial spot and speck in tomato and pepper production.

EcoPhage describes a commercial programme involving repeated foliar applications, normally beginning during vegetative growth and continuing through vulnerable stages. Its current information recommends at least four applications at approximately seven-day intervals, subject to the product label and local requirements.

The company has also submitted four additional products to the EPA. EcoFire targets fire blight in apples and pears. EcoBrass targets black rot of Brassica crops. EcoStraw targets angular leaf spot in strawberries, and EcoSpud targets blackleg and soft rot of potatoes caused by Pectobacterium and Dickeya.

Submission is not approval. Until the EPA completes evaluation, these products should be described as regulatory candidates rather than registered US crop-protection products.

EcoPhage's international agreements need the same distinction. GoldenEco has distribution agreements in Brazil and Mexico, and EcoFire is included in the Mexican agreement with Agricultura Nacional, known as Dragon. These agreements establish commercial partners, but they do not themselves demonstrate that every national pesticide authorization required for use has been completed.

China: the first nationally registered phage crop pesticide

China reached an important regulatory milestone in 2025 when Phagelux Nanjing Biotechnology obtained registrations for Xanthomonas axonopodis phage YHC5.

The technical phage material was registered as PD20252165, while a 5-billion-PFU/mL suspension concentrate intended for citrus-canker control received registration PD20252172.

Chinese regulatory information recommends application by spraying during the early stages of citrus canker, using a 500- to 1,000-fold dilution and repeated treatment at intervals of roughly seven to ten days under the labelled programme.

Phagelux markets its citrus work in China under the LeJu name. Its public crop-science pipeline also identifies LeJiang against Ralstonia solanacearum disease of ginger and LeQi against Pseudomonas syringae disease of kiwifruit.

Those additional programmes should not yet be placed in the same regulatory category as the registered YHC5 citrus product unless national registrations are separately confirmed.

Europe: emergency access rather than a unified market

Europe illustrates how regulatory status can become more complicated than the underlying science.

DCM PEA-02 is a phage cocktail targeting Erwinia amylovora, the bacterium causing fire blight in apples and pears. DCM has submitted a broader European registration dossier, but the permanent procedure remains in progress.

During 2026, several EU countries allowed temporary use through national emergency authorizations. DCM reports access during defined periods in Belgium, Portugal, Spain, Germany, France and Greece.

These authorizations are temporary and geographically limited. A farmer in France cannot assume that a Belgian authorization applies, and an authorization that was valid during the spring may no longer be valid later in the year.

This is why European growers should check their national plant-protection database immediately before purchase or application rather than relying on an old article or distributor page.

Hungary has separately supported fire-blight phages through the Erwiphage family developed by Enviroinvest. Erwiphage, Erwiphage Forte and Erwiphage Plus have been used under temporary national arrangements during earlier seasons, with cocktails adapted to E. amylovora populations.

The associated PhageFire project brought together Enviroinvest, Switzerland's ZHAW, Kimitec and Spanish fruit producer Peras de Rincón de Soto to develop a broader commercial phage solution for apple, pear and quince orchards. PhageFire remains better described as a development and commercialization programme than as a generally authorized EU pesticide.

Canada

Canada has one of the earlier regulatory examples outside the United States.

AgriPhage CMM was registered for control of tomato bacterial canker caused by Clavibacter michiganensis in greenhouse tomatoes. Canadian agricultural authorities list OmniLytics as the manufacturer and registration number 30301 for the product.

That authorization is considerably narrower than the full US AgriPhage portfolio. A Canadian grower should therefore not assume that every AgriPhage formulation registered by the US EPA can automatically be purchased or legally used in Canada.

Mexico and Brazil

Latin America is becoming commercially important because of its large fruit and vegetable production and favourable climate for several bacterial crop diseases.

EcoPhage has conducted multiple seasons of GoldenEco field trials in Mexico and subsequently signed a distribution agreement with Agricultura Nacional/Dragon in October 2026 covering GoldenEco and EcoFire.

The company had already signed a distribution agreement with Maian for GoldenEco in Brazil in 2024.

Neither announcement should be converted into a claim that the product has obtained complete national pesticide registration. Distribution, import arrangements, field trials and pesticide authorization are separate stages.

Farmers in either country should therefore ask the distributor for the current local registration number, approved crops, application label and sale date before purchasing.

Bananas in Central and Latin America

EcoStonia targets Moko disease of banana associated with Ralstonia solanacearum. Unlike GoldenEco, it is not presented here as a fully registered commercial pesticide.

In 2026, EcoPhage and Dole Fresh Fruit International announced an evaluation and pre-commercialization agreement to assess phage-based control of Moko and related bacterial diseases across banana operations in Latin America.

This is an important development because Moko management often relies heavily on surveillance, quarantine and destruction of infected plants. A targeted biological treatment could potentially complement biosecurity if field efficacy and regulatory authorization are ultimately demonstrated.

At present, however, EcoStonia belongs in the development category rather than the same category as an EPA-registered AgriPhage formulation.

How farmers actually use phages

Most crop-protection phages are applied to leaves, blossoms or fruit surfaces as aqueous sprays. The objective is to place enough viable phage particles where the pathogenic bacteria are likely to be encountered.

Timing can be more important than with persistent chemical pesticides because phages usually do not remain indefinitely on exposed plant surfaces. Sunlight, particularly ultraviolet radiation, can rapidly reduce infectivity. Heat, desiccation and some agricultural chemicals can also reduce viability.

This frequently favours evening or early-morning application and repeated spraying during periods of disease pressure. The exact strategy must come from the registered label because the interval, concentration, crop stage and permitted number of applications differ between products.

Rain presents a second problem. A strong rainfall event can remove a foliar phage preparation before sufficient interaction with the pathogen occurs.

Formulation research therefore focuses increasingly on UV protection, adhesion, shelf stability and improved persistence. These characteristics can matter as much commercially as the ability of an isolated phage to kill bacteria in a petri dish.

Preventive or curative?

The answer depends on the product and infection site.

Phages can kill bacteria already present, so they have a biological mechanism that can operate after exposure to the pathogen. However, this should not be interpreted as an ability to reverse unlimited established plant damage.

Once a vascular infection has destroyed substantial tissue, killing the remaining bacteria cannot regenerate dead branches, fruit or vascular structures.

Many programmes therefore use phages preventively or at the first signs of disease, when bacterial populations remain accessible and plant damage is limited.

XylPhi-PD is unusual because direct xylem injection attempts to reach a vascular pathogen already living inside the vine.

Why cocktails matter

A single phage normally infects only part of the genetic diversity present within a bacterial species.

Commercial products consequently often contain several phages recognizing different bacterial receptors. If one bacterium becomes resistant to one phage by changing a receptor, another cocktail component may still infect it through a different route.

This reduces, but does not eliminate, resistance.

Claims that bacteria cannot become resistant to agricultural phages should therefore be treated cautiously. Phage resistance is biologically possible and well documented. The objective is to build cocktails, update formulations and integrate phages into IPM programmes in ways that reduce the probability that resistance compromises control.

Some companies maintain regional pathogen collections precisely for this reason. OmniLytics describes repeated sampling and reformulation of its AgriPhage products to maintain coverage against changing field populations.

Advantages for growers

The strongest advantage is specificity. Phages can suppress the bacterial pathogen while placing much less direct pressure on unrelated organisms than a broad-spectrum antibacterial compound.

They can also remain active against bacteria resistant to copper or antibiotics because their killing mechanism is entirely different.

Residue management is another attraction. Several US phage products have received tolerance exemptions, and many are compatible with organic-production systems when their specific registration and certification allow it.

Phage cocktails can also be updated more readily than a conventional synthetic active ingredient when pathogen populations change, although regulatory systems may restrict how easily a commercial composition can be modified.

Finally, the technology is particularly attractive where few conventional bactericides work well. Plant bacterial diseases are notoriously difficult to control, and resistance to copper or antibiotics has reduced the reliability of some existing programmes.

The disadvantages are equally important

Phages are much more biologically fragile than many chemical pesticides. UV exposure, temperature, water quality and tank chemistry can determine whether an application contains active viruses when it reaches the crop.

Narrow host range means diagnosis matters. A product targeting Xanthomonas cannot be assumed to work when visually similar symptoms are actually caused by fungi, abiotic stress or another bacterial species.

Resistance remains possible, especially if one phage or one receptor is repeatedly exposed to large pathogen populations.

Coverage is another challenge. A phage cannot kill a bacterium it never encounters. Dense plant structures, internal infections and biofilms can limit access.

Storage requirements and shelf life also matter because viruses can lose infectivity under unsuitable conditions.

Finally, phages do not remove the need for agronomy. Resistant varieties, sanitation, vector control, removal of infected plant material, irrigation management and other IPM practices remain important.

Can phages be mixed with copper, antibiotics or fungicides?

Sometimes, but not automatically.

Some fungicides, insecticides, fertilizers and surfactants have little effect on a particular phage formulation, while certain antimicrobial products can rapidly destroy it.

Copper is especially important because copper compounds are used against many of the same bacterial diseases that phages target. Depending on formulation and concentration, simultaneous tank mixing can reduce phage viability.

Chlorinated irrigation or spray water can produce the same problem.

The product manufacturer should therefore provide actual compatibility data. Farmers should not extrapolate compatibility from one phage product to another.

Sequential treatment may sometimes be preferable to simultaneous mixing.

How much do phage biopesticides cost?

There is no useful universal price.

Most professional crop-protection phage products are sold through agricultural distributors and pricing depends on country, acreage, crop, labelled application rate, number of applications, freight and commercial contract.

Public retail prices are therefore much less informative than the cost per treated hectare or acre over an entire disease-management programme.

XylPhi-PD creates an additional labour consideration because vines are individually injected rather than sprayed.

For products requiring repeated weekly foliar applications, the cost of labour and machinery can be as important as the price of the phage concentrate itself.

Growers comparing phages with copper or conventional bactericides should therefore ask for a full seasonal programme cost rather than simply the price of one container.

Where to buy or ask for access

In the United States, AgriPhage products are available through OmniLytics/Phagelux agricultural channels and regional crop-protection distributors. OmniLytics publishes its commercial contact at sales@agriphage.com and +1 801 746 3600.

XylPhi-PD is produced by A&P Inphatec and is distributed in California through Wilbur-Ellis agricultural locations. Availability outside California must be checked against current state registration.

EcoPhage has appointed CNI AG as a non-exclusive US commercial partner for GoldenEco following EPA approval. State registration remains relevant before use.

In Mexico, EcoPhage has selected Agricultura Nacional/Dragon for GoldenEco and EcoFire. In Brazil, Maian is its GoldenEco partner. Farmers should obtain confirmation of national authorization before treating crops.

European growers interested in DCM PEA-02 should contact DCM or their professional plant-protection distributor and verify the current emergency or national authorization in their country.

Chinese growers and distributors can contact Phagelux AgriHealth / Phagelux Nanjing Biotechnology for its registered citrus product and regional crop-science portfolio.

Prices are generally supplied through quotation rather than maintained as global public list prices.

What farmers should ask before buying

Before purchasing a phage product, the first question should be whether the bacterial diagnosis has actually been confirmed. Phages are too specific to justify treating an uncertain disease diagnosis.

The second question is whether the product is legally authorized for that crop and country at that moment. A US EPA registration does not authorize use in France, Brazil or Mexico, and an EU emergency authorization can expire within months.

Farmers should then ask which pathogen strains the product covers, how frequently it must be applied, which water conditions are acceptable, which pesticides can be tank mixed with it and how the product must be stored.

Shelf life and transport conditions are particularly important for live biological products.

The final question should concern the whole treatment programme: what else must be done alongside the phage? In most situations the best use of bacteriophages will be as one component of integrated disease management rather than as a stand-alone rescue treatment after severe disease has already developed.

How to interpret efficacy claims

Commercial websites frequently report percentage disease reductions, yield gains or superiority over copper treatments. Those data can be useful, but their evidentiary strength varies considerably.

A replicated peer-reviewed field trial is not equivalent to a company demonstration trial. A greenhouse result cannot automatically predict open-field performance. A trial in California cannot automatically predict performance in humid tropical production.

Disease incidence, disease severity and crop yield are also different outcomes.

The most useful evidence is therefore product-specific, pathogen-specific and geographically relevant. Farmers should ask distributors for replicated trial reports conducted under conditions similar to their own production system.

The regulatory problem

Phages create an unusual challenge for pesticide regulators because they are living and evolvable biological agents.

A conventional pesticide normally has a fixed active substance. Phage developers may want to replace one member of a cocktail when bacterial populations evolve or when a new regional strain becomes dominant.

Scientifically, that flexibility is one of phage technology's advantages. Regulators, however, need to know exactly which biological agents are present in a registered product and whether changes alter its safety or environmental profile.

How authorities eventually manage interchangeable or adaptable phage cocktails may therefore determine whether these products can realize their full biological potential.

The difference between the United States and Europe already illustrates this. The United States has accumulated two decades of experience with microbial phage pesticide registrations, while European companies are still using emergency national pathways as permanent registration processes develop.

China's YHC5 approval adds another regulatory model and is particularly important because it gives phage crop protection access to one of the world's largest agricultural markets.

Commercial product or research project?

For readers trying to follow the field, four categories are useful.

A registered product has obtained the relevant pesticide authorization for specific uses in a particular jurisdiction. AgriPhage products, XylPhi-PD, GoldenEco in the US and YHC5 in China fit this category.

An emergency-authorized product may legally be used only in a defined country, crop and period. DCM PEA-02 in several European countries during 2026 is the clearest current example.

A submitted product has entered regulatory review but cannot yet be described as approved. EcoFire, EcoBrass, EcoStraw and EcoSpud are currently examples in the United States.

A development programme may have strong laboratory or field evidence but still lack commercial authorization. EcoStonia and PhageFire belong closer to this category.

Keeping these categories separate prevents a large amount of confusion in discussions of agricultural phages.

What the market looks like now

The agricultural phage market is no longer purely experimental.

US growers have access to multiple EPA-registered phage bactericides covering several economically important crops. China now has a registered citrus-canker phage pesticide. European growers have begun receiving seasonal emergency access to fire-blight phages. EcoPhage, Phagelux, DCM, A&P Inphatec and other groups are expanding the commercial and regulatory pipeline.

But the technology remains early.

There is still no global catalogue comparable with the major chemical pesticide databases, regulatory status varies by country and many product claims come directly from manufacturers rather than independent replicated studies.

The most realistic future for phage biopesticides is therefore not the immediate replacement of conventional crop protection. It is their integration into programmes where bacterial disease is difficult to manage, conventional agents are losing efficacy or growers need more targeted biological tools.

For farmers, the central rule is simple: identify the bacterium first, verify that the phage product covers it, confirm that the product is legally authorized locally, and use it according to the biological conditions that keep the phages alive.

When those four conditions are met, bacteriophages are no longer simply an experimental idea. In several agricultural markets, they are already part of real crop-protection practice.

Sources :

OmniLytics / Phagelux AgriHealth — AgriPhage product portfolio and US registrations. The company lists five US crop bactericides covering spot and speck, tomato canker, fire blight, citrus canker, and nut/stone-fruit bacterial diseases. AgriPhage
https://agriphage.com/product-info/
https://agriphage.com/faq/

Agriculture and Agri-Food Canada — AgriPhage CMM. Canadian authorities list the OmniLytics bacteriophage product for Clavibacter michiganensis and its 2012 registration. Agriculture et Agroalimentaire Canada
https://agriculture.canada.ca/en/science/agriculture-and-agri-food-research-centres/pest-management-centre/pest-management-centre-status-reports-biopesticide-projects

A&P Inphatec / Otsuka — XylPhi-PD. XylPhi-PD is a phage bactericide against Xylella fastidiosa in grapevines and is commercially used, particularly in California. The current label is EPA Reg. 93909-1. Otsuka America
https://inphatec.com/
https://www.otsuka.co.jp/en/company/newsreleases/2021/20210427_1.html

EcoPhage — GoldenEco. EPA approval was announced September 16, 2026, opening the US commercialization pathway subject to state requirements. PR Newswire
https://ecophage.com/products/goldeneco/

EcoPhage — EcoFire, EcoBrass, EcoStraw and EcoSpud. These products have entered the US regulatory process but should not yet be described as EPA-approved products. EcoPhage
https://ecophage.com/news/

EcoPhage — Mexico distribution agreement. Agricultura Nacional/Dragon will initially handle GoldenEco and EcoFire; the announcement itself does not establish Mexican pesticide authorization. PR Newswire
https://www.prnewswire.com/news-releases/ecophage-and-agricultura-nacional-sign-a-distribution-agreement-for-mexico-302908142.html

EcoPhage — Brazil distribution agreement. Maian was appointed to market GoldenEco in Brazil; distribution should be distinguished from regulatory authorization. EcoPhage
https://ecophage.com/ecophage-and-maian-have-entered-into-a-distribution-agreement-for-brazil/

EcoPhage / Dole — EcoStonia and Moko disease. The parties announced an evaluation and pre-commercialization programme for banana production in Latin America. EcoPhage
https://ecophage.com/ecophage-and-dole-food-company-announce-advances-in-biopesticides-application-against-moko-threat-to-banana-production/

DCM — PEA-02. DCM reports a pending European registration process and 2026 emergency authorizations in Belgium, Portugal, Spain, Germany, France and Greece. DCM
https://dcm-info.com/innovations/dcm-pea-02-the-innovative-and-sustainable-biocontrol-product-against-fire-blight

PhageFire Consortium. The European project aims to develop a commercial phage cocktail against Erwinia amylovora for apple, pear and quince while pursuing regulatory pathways. PhageFire
https://www.phagefire.eu/

Phagelux AgriHealth — China crop-science portfolio. The company lists LeJu against citrus canker, LeJiang against ginger wilt and LeQi against kiwifruit disease. Phagelux
https://phage.com/products/

China pesticide-registration reporting — YHC5. Chinese regulatory reporting lists technical registration PD20252165 and formulated product PD20252172 against citrus canker, obtained by Phagelux Nanjing Biotechnology in 2025. Pesticide News
https://www.pesticidenews.cn/zgny/zlzs/content/521629be-ae12-4ca5-8966-c679d30fcc1f.html

Choudhary M. et al. — “Bacteriophages as Agents for Plant Disease Control: Where Are We After a Century?” Viruses 17, 1033 (2025). Broad review of phage crop protection, commercial products and remaining technological barriers. PubMed Central (PMC)
https://doi.org/10.3390/v17081033

“Phage Therapy in Plant Disease Management: 110 Years of History, Current Challenges, and Future Trends.” Plants 15, 368 (2026). Provides an updated overview of registered US products, Canadian registration, historic European products and regulatory development. MDPI
https://doi.org/10.3390/plants15030368

Buttimer C. et al. / Annual Review context — virus-based biological control for plant protection. The review discusses field efficacy, XylPhi-PD, Erwiphage and the regulatory differences between North America and Europe. doi.org
https://doi.org/10.1146/annurev-phyto-021621-114208